Interact to see
Advertisement
Advertisement
ADNRX vs FSMAX
ADNRX vs FSMAX Comparison
Open Charts ADNRX vs FSMAX
American Beacon ARK Transfmt Innov R6
Price$23.59
Change-$0.18 (-0.76%)
VolumeN/A
Net Assets232.03M
Fidelity Extended Market Index
Price$100.75
Change-$0.22 (-0.22%)
VolumeN/A
Net Assets41.44B
ADNRX vs FSMAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
ADNRX vs. FSMAX commentary
Oct 19, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADNRX is a Hold and FSMAX is a Hold.
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 41.4B vs. ADNRX (232M). FSMAX pays higher dividends than ADNRX: FSMAX (0.44) vs ADNRX (0.00). ADNRX was incepted earlier than FSMAX: ADNRX (5 years) vs FSMAX (14 years). ADNRX (1.13) is less costly to investors than FSMAX (0.04). ADNRX is a more actively managed with annual turnover of: 46.00 vs. FSMAX (15.00). ADNRX (0) and FSMAX (0) have matching initial minimum investment requirements. ADNRX annual gain was more profitable for investors over the last year : 82.30 vs. FSMAX (12.72).
| ADNRX | FSMAX | ADNRX / FSMAX | |
| Total Expense Ratio | 1.00 | 0.04 | 2,857% |
| Annual Report Gross Expense Ratio | 1.13 | 0.04 | 3,229% |
| Fund Existence | 5 years | 14 years | - |
| Gain YTD | 51.315 | 10.860 | 472% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 232M | 41.4B | 1% |
| Annual Yield % from dividends | 0.00 | 0.44 | - |
| Returns for 1 year | 82.30 | 12.72 | 647% |
| Returns for 3 years | 117.22 | 63.57 | 184% |
| Returns for 5 years | N/A | 48.84 | - |
| Returns for 10 years | N/A | 103.74 | - |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement